biotech.today

Details

  • ●Modalities: enzymes, proteins
  • ●Therapeutic areas: Undisclosed
  • ●Key targets:
  • ●Indications: Undisclosed
  • ●Funding: Undisclosed

Partners & investors

  • Microsoft· Investor

Key considerations

  • ●AI tools in use: Arzeda Platform
  • ●Microsoft backing
  • ●Multiple industrial biotech partnerships
Get live updates on Arzeda’s hiring, filings, and partnerships. Follow in BT Pro →
Source: Company website, SEC / Companies House filings, press releases, Crunchbase · biotech.today analysis (Apr 2026)

Key people

Alexandre Zanghellini

Co-Founder & CEO

computational-protein-design
Visit website →LinkedIn →